MicroHarvest, the Hamburg-based biotechnology innovator, has confirmed the site for its first commercial-scale production facility, selecting Industriepark Leuna in Saxony-Anhalt, Germany. The decision follows a rigorous evaluation of approximately 40 potential locations across Europe, with Leuna securing the bid due to its established industrial infrastructure and proximity to regional feedstocks.
The new plant represents a significant step in the industrialisation of microbial fermentation for the food sector. Backed by a mid-range double-digit million euro investment and a €5.46 million federal grant, the facility is designed to produce 15,000 tonnes of sustainable protein ingredients annually.
The Leuna Advantage
Industriepark Leuna is one of Germany's largest chemical industrial hubs. MicroHarvest cited the site's "industrial backbone" as a decisive factor, specifically its robust utility access and logistical connections.
Crucially, the location offers proximity to regional agri-food suppliers, providing a steady stream of molasses and other byproducts which serve as the primary feedstock for MicroHarvest’s fermentation process. This allows the company to execute a circular economy model, converting agricultural waste into high-value protein within a 24-hour production cycle.
Funding and Scale-Up
The project has received substantial public backing, securing an EEW grant (Federal Funding Programme for Energy and Resource Efficiency in Industry) of up to €5.46 million.
Katelijne Bekers, Co-Founder and CEO of MicroHarvest, framed the investment as a matter of continental food security.
"This project is about strengthening European supply resilience by adding a new, scalable protein ingredient pathway that is independent of seasons and climate volatility," Bekers said. "Leuna gives us the industrial backbone and the regional ecosystem to execute."
Commercial Outlook
With production targeted to commence in approximately two years, MicroHarvest is positioning itself to meet growing demand across three distinct sectors:
Aquaculture: Seeking sustainable replacements for fishmeal.
Pet Food: Driving demand for alternative, hypoallergenic proteins.
Human Food: Ingredients for functional foods and meat alternatives.
The company reports strong demand visibility for the planned capacity and is actively engaged in discussions with both multinational customers and mid-sized white-label manufacturers. The facility is expected to create approximately 25 high-skilled jobs in the region.

.png)






